147 related articles for article (PubMed ID: 25661038)
1. Detection of new biased agonists for the serotonin 5-HT2A receptor: modeling and experimental validation.
Martí-Solano M; Iglesias A; de Fabritiis G; Sanz F; Brea J; Loza MI; Pastor M; Selent J
Mol Pharmacol; 2015 Apr; 87(4):740-6. PubMed ID: 25661038
[TBL] [Abstract][Full Text] [Related]
2. Identification of structural determinants of ligand selectivity in 5-HT₂ receptor subtypes on the basis of protein-ligand interactions.
Jang JW; Kim MS; Cho YS; Cho AE; Pae AN
J Mol Graph Model; 2012 Sep; 38():342-53. PubMed ID: 23085173
[TBL] [Abstract][Full Text] [Related]
3. G protein- and agonist-bound serotonin 5-HT2A receptor model activated by steered molecular dynamics simulations.
Isberg V; Balle T; Sander T; Jørgensen FS; Gloriam DE
J Chem Inf Model; 2011 Feb; 51(2):315-25. PubMed ID: 21261291
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, binding affinity, and molecular docking analysis of new benzofuranone derivatives as potential antipsychotics.
Aranda R; Villalba K; Raviña E; Masaguer CF; Brea J; Areias F; Domínguez E; Selent J; López L; Sanz F; Pastor M; Loza MI
J Med Chem; 2008 Oct; 51(19):6085-94. PubMed ID: 18783204
[TBL] [Abstract][Full Text] [Related]
5. Binding modes of chain arylpiperazines to 5-HT1a, 5-HT2a and 5-HT7 receptors.
Bielenica A; Kozioł AE; Struga M
Mini Rev Med Chem; 2013 Aug; 13(10):1516-39. PubMed ID: 24568298
[TBL] [Abstract][Full Text] [Related]
6. Activation of Akt through 5-HT2A receptor ameliorates serotonin-induced degradation of insulin receptor substrate-1 in adipocytes.
Li Q; Hosaka T; Harada N; Nakaya Y; Funaki M
Mol Cell Endocrinol; 2013 Jan; 365(1):25-35. PubMed ID: 22975078
[TBL] [Abstract][Full Text] [Related]
7. Overcoming Depression with 5-HT
Zięba A; Stępnicki P; Matosiuk D; Kaczor AA
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008436
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and binding affinity of potential atypical antipsychotics with the tetrahydroquinazolinone motif.
Carro L; Raviña E; Domínguez E; Brea J; Loza MI; Masaguer CF
Bioorg Med Chem Lett; 2009 Nov; 19(21):6059-62. PubMed ID: 19796944
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of bidentate ligands designed to interact with PDZ domains.
Boucherle B; Vogrig A; Deokar H; Bouzidi N; Ripoche I; Thomas I; Marin P; Ducki S
Bioorg Med Chem; 2011 Jul; 19(14):4346-54. PubMed ID: 21680189
[TBL] [Abstract][Full Text] [Related]
10. Asymmetric total synthesis and identification of tetrahydroprotoberberine derivatives as new antipsychotic agents possessing a dopamine D(1), D(2) and serotonin 5-HT(1A) multi-action profile.
Sun H; Zhu L; Yang H; Qian W; Guo L; Zhou S; Gao B; Li Z; Zhou Y; Jiang H; Chen K; Zhen X; Liu H
Bioorg Med Chem; 2013 Feb; 21(4):856-68. PubMed ID: 23332346
[TBL] [Abstract][Full Text] [Related]
11. Multiparameter optimization in CNS drug discovery: design of pyrimido[4,5-d]azepines as potent 5-hydroxytryptamine 2C (5-HT₂C) receptor agonists with exquisite functional selectivity over 5-HT₂A and 5-HT₂B receptors.
Storer RI; Brennan PE; Brown AD; Bungay PJ; Conlon KM; Corbett MS; DePianta RP; Fish PV; Heifetz A; Ho DK; Jessiman AS; McMurray G; de Oliveira CA; Roberts LR; Root JA; Shanmugasundaram V; Shapiro MJ; Skerten M; Westbrook D; Wheeler S; Whitlock GA; Wright J
J Med Chem; 2014 Jun; 57(12):5258-69. PubMed ID: 24878222
[TBL] [Abstract][Full Text] [Related]
12. In vitro functional evaluation of isolaureline, dicentrine and glaucine enantiomers at 5-HT
Heng HL; Chee CF; Thy CK; Tee JT; Chin SP; Herr DR; Buckle MJC; Paterson IC; Doughty SW; Abd Rahman N; Chung LY
Chem Biol Drug Des; 2019 Feb; 93(2):132-138. PubMed ID: 30216681
[TBL] [Abstract][Full Text] [Related]
13. Molecular modelling of human 5-hydroxytryptamine receptor (5-HT2A) and virtual screening studies towards the identification of agonist and antagonist molecules.
Gandhimathi A; Sowdhamini R
J Biomol Struct Dyn; 2016 May; 34(5):952-70. PubMed ID: 26327576
[TBL] [Abstract][Full Text] [Related]
14. Atypical antipsychotics and inverse agonism at 5-HT2 receptors.
Sullivan LC; Clarke WP; Berg KA
Curr Pharm Des; 2015; 21(26):3732-8. PubMed ID: 26044975
[TBL] [Abstract][Full Text] [Related]
15. Molecular modeling and docking study on dopamine D2-like and serotonin 5-HT2A receptors.
Duan X; Zhang M; Zhang X; Wang F; Lei M
J Mol Graph Model; 2015 Apr; 57():143-55. PubMed ID: 25728902
[TBL] [Abstract][Full Text] [Related]
16. Clozapine as the most efficacious antipsychotic for activating ERK 1/2 kinases: Role of 5-HT
Aringhieri S; Kolachalam S; Gerace C; Carli M; Verdesca V; Brunacci MG; Rossi C; Ippolito C; Solini A; Corsini GU; Scarselli M
Eur Neuropsychopharmacol; 2017 Apr; 27(4):383-398. PubMed ID: 28283227
[TBL] [Abstract][Full Text] [Related]
17. AlphaFold2 structures guide prospective ligand discovery.
Lyu J; Kapolka N; Gumpper R; Alon A; Wang L; Jain MK; Barros-Álvarez X; Sakamoto K; Kim Y; DiBerto J; Kim K; Glenn IS; Tummino TA; Huang S; Irwin JJ; Tarkhanova OO; Moroz Y; Skiniotis G; Kruse AC; Shoichet BK; Roth BL
Science; 2024 Jun; 384(6702):eadn6354. PubMed ID: 38753765
[TBL] [Abstract][Full Text] [Related]
18. Optimization of 2-phenylcyclopropylmethylamines as selective serotonin 2C receptor agonists and their evaluation as potential antipsychotic agents.
Cheng J; Giguère PM; Onajole OK; Lv W; Gaisin A; Gunosewoyo H; Schmerberg CM; Pogorelov VM; Rodriguiz RM; Vistoli G; Wetsel WC; Roth BL; Kozikowski AP
J Med Chem; 2015 Feb; 58(4):1992-2002. PubMed ID: 25633969
[TBL] [Abstract][Full Text] [Related]
19. Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells.
Cussac D; Boutet-Robinet E; Ailhaud MC; Newman-Tancredi A; Martel JC; Danty N; Rauly-Lestienne I
Eur J Pharmacol; 2008 Oct; 594(1-3):32-8. PubMed ID: 18703043
[TBL] [Abstract][Full Text] [Related]
20. In vitro, molecular modeling and behavioral studies of 3-{[4-(5-methoxy-1H-indol-3-yl)-1,2,3,6-tetrahydropyridin-1-yl]methyl}-1,2-dihydroquinolin-2-one (D2AAK1) as a potential antipsychotic.
Kaczor AA; Targowska-Duda KM; Budzyńska B; Biała G; Silva AG; Castro M
Neurochem Int; 2016 Jun; 96():84-99. PubMed ID: 26964765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
